Updated July 2026 · 8 min read

Catastrophic Antiphospholipid Syndrome (CAPS) for ICU Nurses 2026 — When Clots Attack Every Organ at Once

Part of the ICU Emergencies Hub — browse every related guide in one place.

Most of the clotting emergencies you see in the unit hit one place at a time: a PE, a limb ischemia, a stroke. Catastrophic antiphospholipid syndrome is different, and it is genuinely one of the most dramatic diagnoses in critical care. Over a matter of days, a patient's blood begins clotting off small vessels in organ after organ — kidneys, lungs, brain, heart, skin, gut — all at once. The labs look like a mix of a clotting disorder and multi-organ failure, and the temptation is to chase each failing organ separately. But the unifying story is a thrombotic storm driven by antiphospholipid antibodies, and it carries a mortality that is frightening if it is not recognized and treated aggressively and fast. Knowing that a young patient with a lupus or clotting history who is failing multiple organs might have CAPS — and that the treatment is anticoagulation plus immunosuppression, not just organ support — is a diagnosis-saving piece of knowledge.

A thrombotic storm, not a bleeding one

Antiphospholipid syndrome is an autoimmune condition in which antibodies against phospholipid-binding proteins make the blood prone to clotting; in its ordinary form it causes DVTs, strokes, and recurrent miscarriage. The "catastrophic" variant is the rare, accelerated version — fewer than 1 percent of APS patients — where instead of one clot, the patient develops clots throughout the small vessels of multiple organs almost simultaneously. Something usually lights the fuse: an infection, surgery, a flare of underlying lupus, or interruption of the patient's anticoagulation. Within days, microthrombi choke the circulation of the kidneys (rising creatinine, hypertension), the lungs (ARDS-like failure, PE), the brain (confusion, stroke, seizures), the heart (microvascular ischemia, valve involvement), the skin (livedo, digital ischemia, necrosis), and the gut. Because so many systems fail together, CAPS can masquerade as sepsis with multi-organ dysfunction — and the clue that it is not simply sepsis is the pattern of thromboses combined with a history of clotting or autoimmune disease and the presence of antiphospholipid antibodies.

Telling it apart from DIC and TTP

CAPS lives in the same neighborhood as the other thrombotic microangiopathies, and part of the nurse's mental model is knowing they are different diseases with different treatments. In DIC, the coagulation cascade is consumed — fibrinogen falls, D-dimer soars, the patient both clots and bleeds — and it is usually driven by sepsis or obstetric catastrophe. In TTP, a deficiency of the ADAMTS13 enzyme causes platelet-rich clots with a classic pentad (microangiopathic hemolytic anemia with schistocytes, low platelets, neurologic changes, kidney injury, fever), and the treatment is urgent plasma exchange. CAPS overlaps with both but is defined by antiphospholipid antibodies and the rapid multi-organ small-vessel thrombosis; it may coexist with a consumptive picture, which is exactly why it gets mislabeled. The practical point is not that a nurse makes the distinction alone, but that recognizing "multi-organ thrombosis in a patient with APS or lupus" prompts the specific workup (antiphospholipid antibody testing, a hematology and rheumatology consult) that unlocks the right therapy.

Triple therapy: hit the clotting and the immune system together

CAPS is one of the clearest examples in medicine of a disease where you must treat several things at once and quickly. The backbone is triple therapy: full anticoagulation (usually IV heparin) to stop new clot formation; high-dose corticosteroids to quiet the autoimmune/inflammatory storm; and plasma exchange and/or IVIG to remove or neutralize the pathogenic antiphospholipid antibodies. On top of that, any trigger is treated — antibiotics if infection set it off — and refractory cases may receive rituximab or eculizumab. Everything else is organ support: dialysis for the failing kidneys, ventilation for the lungs, and so on. For nursing, a CAPS patient is intensely complex: you are running a heparin drip and watching for bleeding while the patient is simultaneously clotting, managing plasma exchange with its access and citrate/calcium considerations, giving high-dose steroids and monitoring glucose and infection risk, and supporting multiple failing organ systems in parallel. The mortality is high, and time to recognition and to starting triple therapy is one of the strongest levers on survival — which is exactly why a nurse who can flag the pattern earns the patient a real chance.

The nursing bottom line

Catastrophic antiphospholipid syndrome is a thrombotic storm: antiphospholipid antibodies drive small-vessel clots that shut down three or more organs within days, often after an infection, surgery, or an interrupted anticoagulant. It hides behind a sepsis-and-multi-organ-failure picture, and the discriminating clue is widespread thrombosis in a patient with lupus or a known clotting disorder. It is not DIC and not TTP, though it overlaps. The treatment that changes the odds is prompt triple therapy — anticoagulation, high-dose steroids, and plasma exchange/IVIG — layered onto trigger control and organ support. Recognizing that failing organs plus a clotting-autoimmune history equals a possible CAPS storm, and pushing for the antiphospholipid workup and hematology involvement early, is the nursing contribution that gets this patient onto the therapy that saves lives.

Related:

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.